Hepatitis C virus core protein potentiates c-Jun N-terminal kinase activation through a signaling complex involving TRADD and TRAF2

Virus Research

Volumn 74, Issue 1-2, 2001, Pages 89-98

  Park, Kyu Jin ^a,b   Choi, Soo Ho ^a   Koh, Moon Soo ^a   Kim, Dong Joon ^a   Yie, Se Won ^b   Lee, Soo Young ^c   Hwang, Soon B ^a  

^a Hallym University   (South Korea)

^b Kangwon National University   (South Korea)

^c Ewha Womans University   (South Korea)

Author keywords

c Jun N terminal kinase; Hepatitis C virus; Signal transduction; Tumor necrosis factor receptor

Indexed keywords

CORE PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL LINE; CLONING, MOLECULAR; ENZYME ACTIVATION; GLUTATHIONE TRANSFERASE; HEPACIVIRUS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MACROMOLECULAR SUBSTANCES; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 1; TNF RECEPTOR-ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR-ALPHA; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS;

EID: 0035111296     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(00)00251-3     Document Type: Article

References (39)

1. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays
2. The natural history of community-acquired hepatitis C in the United States. The sentinel counties chronic non-A, non-B hepatitis study team
3. Signaling by proinflammatory cytokines: Oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain
4. Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene
5. Full genome cloning and nucleotide sequence analysis of hepatitis C virus from sera of chronic hepatitis patients in Korea
6. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
7. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection
8. Lack of protective immunity against reinfection with hepatitis C virus
9. Expression and identification of hepatitis C virus polyprotein cleavage products
10. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis
11. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation
12. Genomic structure of the human prototype strain H of hepatitis C virus: Comparison with American and Japanese isolates
13. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis
14. Sounding the alarm: Protein kinase cascades activated by stress and inflammation
15. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors
16. Stimulus-dependent synergism of the antiapoptotic tumor necrosis factor receptor-associated factor 2 (TRAF2) and nuclear factor kappaB pathways
17. TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival
18. Processing in the hepatitis C virus E2-NS2 region: Identification of p7 and two distinct E2-specific products with different C termini
19. Differential subcellular localization of hepatitis C virus core gene products
20. Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3
21. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation
22. Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor
23. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway
24. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype
25. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein
26. Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein
27. Transcriptional repression of p53 promoter by hepatitis C virus core protein
28. Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2
29. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma
30. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses
31. Hepatitis C virus as a causative agent of hepatocellular carcinoma
32. Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors
33. Regulation of apoptosis by viral gene products
34. Immunity in chimpanzees chronically infected with hepatitis C virus: Role of minor quasispecies in reinfection
35. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
36. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice
37. Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha
38. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis